Charles Schwab’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
BL
CM
FLPIM
GRP
Charles Schwab's GNLX Position: Q2 2026 in Review
Charles Schwab increased its Genelux (GNLX) stake by 0.09% in Q2 2026, buying an estimated $65 and bringing the position to 25,023 shares worth $75.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.
Charles Schwab first reported a position in GNLX in Q1 2023 and has held it in 12 quarters since. The position peaked at $3.61M in Q3 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.
- Charles Schwab held 25,023 shares of Genelux worth $75.3K as of Q2 2026.
- Charles Schwab bought 23 Genelux shares in Q2 2026, an estimated $65.
- Genelux made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3415 holding.
- Charles Schwab first reported a position in Genelux in Q1 2023 and has held it in 12 quarters since.
- Charles Schwab's Genelux position peaked at $3.61M in Q3 2023.
- 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.